Objective: To measure the HIV seroprevalence rate in a surrogate sampl
e of the general population in the province of Quebec, using a network
of sentinel hospitals. Design: Anonymous unlinked sentinel surveillan
ce study. Setting: Outpatient surgery units in 19 acute care hospitals
throughout Quebec. Participants: All patients attending the outpatien
t surgery units from November 1990 to October 1992. A total of 61 547
plasma samples were obtained from leftover blood samples collected for
cell counts. Fifty samples were excluded because of an insufficient a
mount of plasma and one because of an indeterminate result. Interventi
on: HIV antibody testing with enzyme-linked immunosorbent assay; posit
ive results confirmed with radioimmunoprecipitation assay. Outcome mea
sures: HIV antibody status, sex, year of birth and area of residence.
Results: The crude seroprevalence rate among the subjects aged 15 year
s or more was 0.4 per 1000 population (95% confidence interval [CI] 0.
2 to 0.7) among the women and 3.6 per 1000 population (95% CI 2.8 to 4
.4) among the men (p < 0.001). The rate after adjustment for age, sex
and geographic distribution of the study population was 2.3 per 1000 p
opulation (95% CI 1.9 to 2.7). The seroprevalence rate among the male
patients in the City of Montreal was much higher than the rates elsewh
ere in the province. It increased progressively during each of the fou
r 6-month intervals of the study: 8.1, 8.7, 13.9 and 18.3 per 1000 res
pectively (chi(2) linear trend = 4.76; p = 0.029). No similar trends w
ere observed outside Montreal for the male patients. There were too fe
w seropositive female patients to draw any solid conclusion. Conclusio
ns: Despite the possible drawbacks of a nonrandomized sampling scheme,
this study suggests that in the male population the HIV seroprevalenc
e rate is increasing in Montreal and is stable in all other areas of t
he province. The continued surveillance of HIV infection through anony
mous unlinked studies is useful to monitor trends.